Torsdag 3 Juli | 12:36:32 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-02-12 08:00 Bokslutskommuniké 2025
2025-10-23 08:00 Kvartalsrapport 2025-Q3
2025-07-17 08:00 Kvartalsrapport 2025-Q2
2025-05-09 - X-dag ordinarie utdelning STIL 0.00 SEK
2025-05-07 - Årsstämma
2025-04-24 - Kvartalsrapport 2025-Q1
2025-02-13 - Bokslutskommuniké 2024
2024-10-24 - Kvartalsrapport 2024-Q3
2024-07-18 - Kvartalsrapport 2024-Q2
2024-05-10 - X-dag ordinarie utdelning STIL 0.00 SEK
2024-05-08 - Årsstämma
2024-04-25 - Kvartalsrapport 2024-Q1
2024-02-16 - Bokslutskommuniké 2023
2023-12-29 - Extra Bolagsstämma 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-07-14 - Kvartalsrapport 2023-Q2
2023-05-08 - X-dag ordinarie utdelning STIL 1.80 SEK
2023-05-05 - Årsstämma
2023-04-27 - Kvartalsrapport 2023-Q1
2023-02-17 - Bokslutskommuniké 2022
2022-10-27 - Kvartalsrapport 2022-Q3
2022-07-15 - Kvartalsrapport 2022-Q2
2022-05-06 - X-dag ordinarie utdelning STIL 1.00 SEK
2022-05-05 - Årsstämma
2022-05-01 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-10-27 - Kvartalsrapport 2021-Q3
2021-07-16 - Kvartalsrapport 2021-Q2
2021-05-05 - X-dag ordinarie utdelning STIL 1.70 SEK
2021-05-04 - Årsstämma
2021-04-28 - Kvartalsrapport 2021-Q1
2021-02-18 - Bokslutskommuniké 2020
2020-10-29 - Kvartalsrapport 2020-Q3
2020-08-20 - Kvartalsrapport 2020-Q2
2020-05-28 - X-dag ordinarie utdelning STIL 0.00 SEK
2020-05-27 - Årsstämma
2020-04-29 - Kvartalsrapport 2020-Q1
2020-02-20 - Bokslutskommuniké 2019
2019-10-31 - Kvartalsrapport 2019-Q3
2019-08-22 - Kvartalsrapport 2019-Q2
2019-05-03 - X-dag ordinarie utdelning STIL 1.45 SEK
2019-05-02 - Årsstämma
2019-05-02 - Kvartalsrapport 2019-Q1
2019-02-25 - Bokslutskommuniké 2018
2018-11-22 - Kvartalsrapport 2018-Q3
2018-08-23 - Kvartalsrapport 2018-Q2
2018-05-17 - Kvartalsrapport 2018-Q1
2018-04-23 - X-dag ordinarie utdelning STIL 1.20 SEK
2018-04-20 - Årsstämma
2018-02-22 - Bokslutskommuniké 2017
2017-11-16 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-05-18 - Kvartalsrapport 2017-Q1
2017-04-27 - X-dag ordinarie utdelning STIL 1.00 SEK
2017-04-26 - Årsstämma
2017-02-16 - Bokslutskommuniké 2016
2016-11-17 - Kvartalsrapport 2016-Q3
2016-08-25 - Kvartalsrapport 2016-Q2
2016-05-19 - Kvartalsrapport 2016-Q1
2016-04-29 - X-dag ordinarie utdelning STIL 0.80 SEK
2016-04-28 - Årsstämma
2016-02-18 - Bokslutskommuniké 2015
2015-11-17 - Kvartalsrapport 2015-Q3
2015-08-25 - Kvartalsrapport 2015-Q2
2015-05-19 - Kvartalsrapport 2015-Q1
2015-04-16 - X-dag ordinarie utdelning STIL 0.00 SEK
2015-04-15 - Årsstämma
2015-02-18 - Bokslutskommuniké 2014
2014-11-19 - Kvartalsrapport 2014-Q3
2014-08-28 - Kvartalsrapport 2014-Q2
2014-07-30 - X-dag ordinarie utdelning STIL 1.00 SEK
2014-05-14 - Kvartalsrapport 2014-Q1
2014-04-03 - Årsstämma
2014-02-20 - Bokslutskommuniké 2013
2013-11-28 - Kvartalsrapport 2013-Q3
2013-08-29 - Kvartalsrapport 2013-Q2
2013-05-28 - Kvartalsrapport 2013-Q1
2013-04-26 - X-dag ordinarie utdelning STIL 0.00 SEK
2013-04-25 - Årsstämma
2013-02-20 - Bokslutskommuniké 2012
2012-11-20 - Kvartalsrapport 2012-Q3
2012-08-29 - Kvartalsrapport 2012-Q2
2012-05-16 - Kvartalsrapport 2012-Q1
2012-04-19 - X-dag ordinarie utdelning STIL 0.00 SEK
2012-04-18 - Årsstämma
2012-02-15 - Bokslutskommuniké 2011
2011-11-16 - Kvartalsrapport 2011-Q3
2011-08-24 - Kvartalsrapport 2011-Q2
2011-05-18 - Kvartalsrapport 2011-Q1
2011-04-14 - X-dag ordinarie utdelning STIL 0.00 SEK
2011-04-13 - Årsstämma
2011-02-16 - Bokslutskommuniké 2010
2010-11-24 - Kvartalsrapport 2010-Q3
2010-08-18 - Kvartalsrapport 2010-Q2
2010-04-16 - X-dag ordinarie utdelning STIL 0.00 SEK
2010-04-15 - Kvartalsrapport 2010-Q1
2010-02-19 - Bokslutskommuniké 2009
2009-11-20 - Kvartalsrapport 2009-Q3
2009-08-27 - Kvartalsrapport 2009-Q2
2009-05-15 - X-dag ordinarie utdelning STIL 0.00 SEK
2009-05-14 - Kvartalsrapport 2009-Q1
2009-04-15 - Årsstämma
2008-06-24 - Split STIL 100:1

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Stille utvecklar, tillverkar och marknadsför medicintekniska produkter för specialistkirurger. Prioriterade områden är kirurgiska instrument och specialbord för hjärt-/kärlkirurgi, gynekologi och urologi. Bolagets produkter används idag bland användare på global nivå. Utöver kärnverksamheten erbjuds även instrumentvårdsutbildning. Stille grundades ursprungligen under 1841 och har sitt huvudkontor i Eskilstuna.
2025-07-02 18:15:00

Stille AB (publ) (“Stille”) has entered into an agreement to acquire all shares outstanding in Surgical Holdings (“Surgical Holdings”) for a consideration of approximately GBP 7.7 million (corresponding to SEK 100 million) on a cash and debt-free basis. Through the acquisition, Stille continues its strategic expansion, further strengthening its geographic reach, product- and service offering. For the financial year ending April 2025, Surgical Holdings reported preliminary sales of GBP 6.4 million and adjusted EBITDA of approximately GBP 1.0 million. The acquisition is conditional upon customary closing conditions, including regular approvals of change of control provisions, and is expected to close during Q3 2025.

Background to Surgical Holdings

Surgical Holdings is a UK-based family-owned company specialising in the development, distribution and repair of high-quality surgical instruments. Founded in 1988, the company has established a strong market position in the UK and select international markets through close partnerships with the NHS and by providing high quality products and services. Its offering includes instruments for general surgery and orthopaedics, as well as specialised repair service for surgical instruments, rigid endoscopes and orthopaedic power tools. Surgical Holdings has demonstrated consistent revenue growth and strong profitability in recent years.

Strengthening Stille’s position in the strategically important UK market

The acquisition is closely aligned with Stille’s growth strategy and vision to become a global leader in surgical instruments for selected clinical niches. Through the addition of Surgical Holdings, Stille will broaden its offering and significantly strengthen its position in the UK – one of the largest markets for surgical instruments in the world. The transaction brings complementary capabilities, including a direct sales team covering the entire UK, supported by a specialised repair and service organisation that will support future growth for the entire Stille Group.

“We are excited to welcome Surgical Holdings into the Stille Group. This acquisition further strengthens our position as a premium supplier of surgical instruments and enhances our access to one of the most important markets for surgical instruments in the world. Surgical Holdings’ strong capabilities and product range are highly complementary to our own, and we see significant commercial and operational synergies from adding a direct sales and service organisation in the UK,” says Ulrik Berthelsen, CEO of Stille.

The combined entity

Post-acquisition, Stille will have direct operations in Sweden, Germany, Switzerland, the United Kingdom, the United States, the UAE, and Malaysia. The transaction is expected to be accretive to Stille’s earnings per share from the time of closing, which is expected to take place in Q3 2025. For the financial year ending December 2024, Stille AB reported sales of SEK 569.9 million and EBITDA of SEK 100.8 million. Surgical Holdings reported preliminary sales of GBP 6.4 million and adjusted EBITDA of approximately GBP 1.0 million for the financial year ending April 2025.

“There is tremendous alignment across the Surgical Holdings and Stille brands. This exciting step creates an unrivalled portfolio of innovative instrumentation, devices and servicing”, says Daniel Coole, Managing Director of Surgical Holdings, who will remain in his role and join Stille’s executive management team.

“This acquisition is a positive step forward in the execution of our strategy and fundamentally strengthens our position in the UK market. We are excited to welcome Surgical Holdings to the Stille Group and thereby improving access to our full offering for all UK healthcare providers”, says Jon Sigurdsson, Chairman of the Board of Stille.

Transaction terms and financing

The total consideration of approximately GBP 7.7 million (corresponding to SEK 100 million) will be paid through a combination of cash at hand and debt, and the seller will reinvest c. GBP 0.5 million (SEK 6.5 million) into newly issued shares in Stille post-closing of the transaction. The transaction is conditional upon customary closing conditions, including regular approvals of change of control provisions. Upon closing, Surgical Holdings will be consolidated into Stille’s financial accounts. The seller’s reinvestment in Stille will be made on customary arm’s-length market terms, with completion anticipated in late 2025 or early 2026, at which time the final terms will be disclosed.

Torshälla, Sweden, 2 July 2025